Here is how Ardelyx (ARDX) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Ardelyx (ARDX) This Year?
Related Posts
These ‘underappreciated’ AI stocks could finally get their chance to shine
Other networking-oriented stocks have more than tripled in the past year, but not Cisco and Arista.
2 Popular Artificial Intelligence (AI) Stocks to Sell Before They Fall 50% and 72% in 2026, According to Wall Street Analysts
Shares of Palantir and Intel have more than doubled year to date, but certain Wall Street analysts think the stocks are extremely overvalued.
Schwab U.S. Dividend Equity ETF ( SCHD ) Offers Higher Yield and Lower Fees Than ProShares S&P 500 Dividend Aristocrats ETF ( NOBL )
Both Schwab U.S. Dividend Equity ETF ( NYSEMKT:SCHD ) and ProShares S&P 500 Dividend Aristocrats ETF ( NYSEMKT:NOBL ) offer exposure to U.S….